Navigation Links
Endo Pharmaceuticals Announces Cash Tender Offer for Any and All Outstanding Ledgemont PhaRMA(SM) Secured 16% Notes
Date:8/26/2009

ender deadline") and accepted for payment by Endo Pharmaceuticals Solutions Inc.

Holders must tender their Notes at or prior to the early tender deadline to be eligible to receive the total early consideration of $1,000 per $1,000 principal amount of Notes. Holders who tender their Notes after such time and at or prior to the expiration time will be eligible to receive the tender offer consideration of $950 per $1,000 principal amount of Notes, which is the total early consideration less the early tender payment. Payments for Notes purchased also will include accrued and unpaid interest on the Notes from the last interest payment date for the Notes to, but excluding, the payment date, which will occur on or before the third business day following the date that Endo Pharmaceuticals Solutions Inc. accepts Notes for purchase pursuant to the tender offer or promptly thereafter.

Endo Pharmaceuticals Solutions Inc.'s obligation to accept for purchase and to pay the tender offer consideration or the total early consideration, as outlined in the table above, as applicable, and the accrued and unpaid interest on Notes validly tendered (and not validly withdrawn) pursuant to the tender offer is conditioned upon the satisfaction or waiver of certain conditions. The tender offer is not conditioned upon any minimum principal amount of the Notes being tendered.

Notes tendered prior to the early tender deadline may be validly withdrawn at any time at or prior to 5:00 p.m., New York City time, on September 9, 2009, but not thereafter unless required by law.

Endo Pharmaceuticals Solutions Inc. has retained Morgan Stanley & Co. Incorporated to serve as Dealer Manager for the tender offer. U.S. Bank National Association has been retained to serve as the Depositary for the tender offer.

For additional information regarding the terms of the tender offer, please contact Morgan Sta
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Robin Leedy & Associates Wins Social Media Program For Union Springs Pharmaceuticals
2. Adamas Pharmaceuticals Expands Management Team; Names Michael D. Coffee and Amy K. Patick to Executive Positions
3. Raptor Pharmaceuticals Raises $5 Million
4. Cumberland Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 27, 2009
5. The Rossbacher Law Firm, Hagens Berman Sobol Shapiro LLP, Wilentz Goldman & Spitzer, P.A., Reed Smith LLP and Thompson Hine LLP, Announce the Proposed Settlement of a Class Action Lawsuit Concerning Estratest and Solvay Pharmaceuticals, Inc.
6. NovaBay Pharmaceuticals to Present New Pre-Clinical Data on Lead Anti-Infective Compound for use in Onychomycosis at the 2009 IDSA Annual Meeting
7. Warner Chilcott Acquires P&Gs Global Pharmaceuticals Business
8. Valeant Pharmaceuticals Announces Preliminary Results From Its Phase IIa Retigabine Study for the Treatment of Postherpetic Neuralgia (PHN)
9. Sound Pharmaceuticals Receives an Office of Naval Research Award for Its Hearing Loss Research and Development
10. Adamas Pharmaceuticals Raises $40 Million in Series D Financing
11. Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... What’s next for 14 year old ... Scripps National Spelling Bee? Sririam will visit Philadelphia on ... renowned Wills Eye Hospital.     , The teen from Painted ... one day. , Wills Eye Ophthalmologist-in-Chief, Dr. Julia Haller ... hi-tech visual diagnostic testing. He will also tour ...
(Date:8/27/2014)... Norton HealthDay Reporter , TUESDAY, ... in clinical trials of new heart disease treatments are generally ... study confirms. Experts said the findings, which appear in ... , aren,t surprising -- but they are troubling. "It,s ... select patient population that is not fully representative of the ...
(Date:8/27/2014)... Tejal K. Gandhi, MD, MPH, CPPS, president of the ... Lucian Leape Institute, is among the 100 Most Influential People ... Healthcare magazine. Also on the list are NPSF board members ... NPSF Lucian Leape Institute members Carolyn Clancy, MD; Bob Wachter, ... both the Institute and the NPSF Board of Directors. , ...
(Date:8/27/2014)... Germantown, Md., and Denver (PRWEB) August 27, 2014 ... estate developer , has broken ground on a 79,491 ... Holy Cross Health hospital campus in Germantown, an unincorporated ... Germantown is the third most populous place in Maryland, ... on the Holy Cross Germantown Hospital campus is one ...
(Date:8/27/2014)... jaundice: It,s one of the last things a parent ... condition in babies less than a week old. , ... that a newborn is jaundiced and isn,t adequately eliminating ... to see, and severe jaundice left untreated can harm ... have developed a smartphone application that checks for jaundice ...
Breaking Medicine News(10 mins):Health News:Scripps National Spelling Bee Co-Champion and Aspiring Ophthalmologist Coming to Wills Eye Hospital in Philadelphia 2Health News:Heart Studies Don't Reflect Real-World Patients, Study Finds 2Health News:Heart Studies Don't Reflect Real-World Patients, Study Finds 3Health News:NPSF President Among 100 Most Influential in Health Care 2Health News:NPSF President Among 100 Most Influential in Health Care 3Health News:NexCore Breaks Ground on Medical Office Building on Holy Cross Health Campus in Germantown, Maryland 2Health News:NexCore Breaks Ground on Medical Office Building on Holy Cross Health Campus in Germantown, Maryland 3Health News:NexCore Breaks Ground on Medical Office Building on Holy Cross Health Campus in Germantown, Maryland 4Health News:New smartphone app can detect newborn jaundice in minutes 2Health News:New smartphone app can detect newborn jaundice in minutes 3
... ultrasound to visualise organs and other internal structures of ... a computer model that can predict the sound transmission ... is capable of processing large quantities of data and ... parallel supercomputer. Erasmus University Medical Centre and Oldelft Ultrasound ...
... Hospira, Inc.,(NYSE: HSP ), a global specialty ... B. Begley, chairman and chief,executive officer, and Thomas ... officer, will make a formal presentation at the ... Nov. 12, 2008, in,Phoenix., The presentation is ...
... first-ever study of its kind, a team led ... Harbor-UCLA Medical Center (LA BioMed) report in November,s ... to respond to medication for depression and were less ... Using data from the nation,s largest real-world clinical study ...
... Day statement by,SEIU President Andy Stern:, "Paula Hall ... home and all her savings when she got sick ... "Samara Knight -- a nursing assistant from Cleveland, ... payments and the,medication her son needs -- will vote ...
... by nearly 100%, operating loss reduced by 44%, ... ), a leading provider of quantitative imaging for clinical,trials, ... 2008 were,over $1.8 million, a 33% increase over prior ... 30, 2008 were approximately $5.2,million compared to nearly $4.2 ...
... today announced that the company will report financial results ... fiscal year ending April,24, 2009 on Wednesday, November 19, ... conference call to discuss those results on Thursday, November,20, ... Second Quarter Results Conference Call Instructions, To listen ...
Cached Medicine News:Health News:Response rates to antidepressants differ among English- and Spanish-speaking Hispanics 2Health News:Today We Must Be the Change We Need 2Health News:VirtualScopics Reports Record Third Quarter 2008 Revenue and Gross Profit 2Health News:VirtualScopics Reports Record Third Quarter 2008 Revenue and Gross Profit 3Health News:VirtualScopics Reports Record Third Quarter 2008 Revenue and Gross Profit 4Health News:VirtualScopics Reports Record Third Quarter 2008 Revenue and Gross Profit 5Health News:VirtualScopics Reports Record Third Quarter 2008 Revenue and Gross Profit 6Health News:Cyberonics Announces Conference Call to Discuss Fiscal Year 2009 Second Quarter Financial Results 2
(Date:8/27/2014)... , August 27, 2014 ... Market By Products (Dental Radiology, CAD/CAM, Dental Chairs, Dental Lasers), Current ... by MarketsandMarkets, the global Dental Equipment Market is expected ... million in 2014, growing at a CAGR of ... 95 market data tables and 61 figures spread ...
(Date:8/27/2014)... 27, 2014 Reportlinker.com announces that a ... catalogue: Global Heart Valve Repair and ... About Heart Valve Repair and ... heart which control the flow of blood during ... valve diseases such as valvular stenosis, valvular insufficiency ...
(Date:8/27/2014)... 2014  Hill-Rom Holdings, Inc. (NYSE: HRC ... at the Morgan Stanley Global Healthcare Conference on September ... are invited to listen to the live discussion via ... it directly at http://cc.talkpoint.com/morg007/090814a_ac/?entity=26_7CLOGQP .  A recorded replay ... conclusion of the live event and accessible at the ...
Breaking Medicine Technology:Dental Equipment Market Worth $7,138.9 Million by 2019 2Dental Equipment Market Worth $7,138.9 Million by 2019 3Global Heart Valve Repair and Replacement Market 2014-2018 2Global Heart Valve Repair and Replacement Market 2014-2018 3Global Heart Valve Repair and Replacement Market 2014-2018 4
... UNION CITY, Calif., Feb. 24, 2012  Abaxis, Inc. (NasdaqGS: ... systems, announced today that Clint Severson, chairman and chief ... Health Care Conference and the RBC Capital Markets, 2012 ... scheduled for Monday, February 27, 2012 at 11:30 a.m. ...
... Event details: February 25, 2012 ... Palm Springs Hotel Catalina/Madera Room ... Ameritox(SM), the nation,s leader in pain medication monitoring , will sponsor ... at the American Academy of Pain Medicine,s (AAPM) 28th Annual Meeting in Palm ...
Cached Medicine Technology:Abaxis, Inc. to Present at the Citi 2012 Global Health Care Conference and RBC Capital Markets' 2012 Healthcare Conference 2Abaxis, Inc. to Present at the Citi 2012 Global Health Care Conference and RBC Capital Markets' 2012 Healthcare Conference 3Ameritox Provides Educational Support to Clinicians to Help Reduce Opioid Misuse, Abuse and Diversion 2Ameritox Provides Educational Support to Clinicians to Help Reduce Opioid Misuse, Abuse and Diversion 3
Patent Pending lateral flow assay platform that contributes to increased sensitivty...
Iso-Electric Determination Kit; contains 1 bottle of 40 nm Naked Gold Iso-Electric Determination Kit to optimize gold conjugation of antibodies...
Gold Labeling kit for antibodies, the Coat-Block-Run Conjugation Kit pH 5-8; contains 1 bottle each of 20 nm and 40 nm Naked Gold...
Colloidal Gold Conjugated, Goat anti-rabbit IgG (H&L) - 50 OD...
Medicine Products: